Program areas at The Glaucoma Foundation
See schedule oeducation:1) multiple webinars: what do cold hands have to do with Glaucoma? The promise of optic nerve regeneration;the body-eye relationship how to save The sight of patients with Glaucoma while minimizing adverse reaction from eye drops;insights into Glaucoma & women's health: exploring The impact of menopause and visual function;glaucoma and lifestyle.2) The 28th annual optic nerve rescue and restoration think tank "a patient-centric approach while incorporating The latest science" Glaucoma data integration:overview of databases available to advance Glaucoma knowledge;lessons learned about Glaucoma from The uk biobank;poag genomic architecture;a 360-degree biomedical profile of health: lessons from cardiovascular disease.3) drug re-purposing in glaucoma:insulin signaling and;metformin and glaucoma;glp-1r agonists and glaucoma;4) overview of Glaucoma neuroprotection agents:why do we not have a neuroprotection agent for glaucoma?how can ai help facilitate randomized clinical trials in neuroprotection?5) sex hormones and glaucoma:the role of sex hormones in The pathogenesis of open-angle Glaucoma: evidence from epidemiological studies;estrogen signaling pathways in glaucoma;the biomechanical argument that estrogen plays a role in glaucoma;6) non-iop factors of importance in glaucoma:diet and glaucoma;hypertension, antihypertensive drugs and glaucoma;the impact of Glaucoma on activities of daily living.7) what can tgf do to help patients, researchers, and eyecare providers tackle Glaucoma? :what is The Glaucoma Foundation doing now?what do patients want to see in Glaucoma research?8) start with The younginfo session on Glaucoma for middle and high school students;in coordination with The stem institute at The city college of new york.9) newsletters: tgf produced six electronic newsletters that were distributed to more than 16,000 households. Tgf's quarterly printed newsletters were available for constituents who do not use computers or who prefer to read paper documents. Newsletters include interviews with doctors, researchers, and patients. They cover topics such as advancements in diagnosis and treatment, perspectives on care, and personal stories of living with The disease.
See schedule omedical research:1) genetic predisposition and ophthalmic outcomes;2) optic nerve regeneration;3) using artificial intelligence to reveal blood pressure's role in Glaucoma progression;4) ee-purposing an "old" drug for a new indication: elucidating The peripheral and central effects of glucagon-like peptide 1 receptor agonists to treat Glaucoma; 5) search for functional loxl1 risk alleles with bit-starr;6) vascular genotype-phenotype association in primary open-angle glaucoma;7) investigating The role of impaired mitochondrial dynamics in exfoliation glaucoma;8) uncovering The potential of pericytes as therapeutic targets for glaucoma;9) nicotinamide and pyruvate for neuroenhancement in open-angle Glaucoma: a phase 2 randomized clinical trial.
Grants made by The Glaucoma Foundation
Who funds The Glaucoma Foundation
Grants from foundations and other nonprofits
Personnel at The Glaucoma Foundation
Name | Title | Compensation | Date of data |
---|
Elena Sturman | President and Chief Executive Officer | $350,733 | 2024-07-10 |
Andrea Steele | Director of Operations | | 2023-08-05 |
Angela Cooley | Director of Fundraising | | 2023-08-05 |
Cly Fowkes | Director of Special Projects | $131,902 | 2023-08-05 |
Elena Cly Fowkes | Director of Special Project | $132,623 | 2023-12-31 |
...and 6 more key personnel |
Financials for The Glaucoma Foundation
Revenues | FYE 12/2023 | FYE 12/2022 | % Change |
---|
Total grants, contributions, etc. | $2,676,417 | $2,557,425 | 4.7% |
Program services | $0 | $0 | - |
Investment income and dividends | $386,991 | $135,466 | 185.7% |
Tax-exempt bond proceeds | $0 | $0 | - |
Royalty revenue | $0 | $0 | - |
Net rental income | $0 | $0 | - |
Net gain from sale of non-inventory assets | $1,699,678 | $190,331 | 793% |
Net income from fundraising events | $0 | $0 | - |
Net income from gaming activities | $0 | $0 | - |
Net income from sales of inventory | $0 | $0 | - |
Miscellaneous revenues | $0 | $30,000 | -100% |
Total revenues | $4,763,086 | $2,913,222 | 63.5% |
Organizations like The Glaucoma Foundation
Organization | Type | Location | Revenue |
---|
Pediatric Brain Tumor Foundation of the United States | 501(c)(3) | Winston Salem, NC | $5,058,429 |
Hydrocephalus Association (HA) | 501(c)(3) | Bethesda, MD | $3,628,383 |
Hearing Health Foundation | 501(c)(3) | New York, NY | $3,637,053 |
JBI International (JBI) | 501(c)(3) | New York, NY | $2,989,204 |
International Eye Foundation | 501(c)(3) | Kensington, MD | $1,853,756 |
Research To Prevent Blindness (RPB) | 501(c)(3) | New York, NY | $16,445,230 |
American Association for the Study of Liver Diseases Foundation | 501(c)(3) | Alexandria, VA | $3,617,517 |
Alexander Graham Bell Association for the Deaf and Hard of Hearing | 501(c)(3) | Washington, DC | $1,613,016 |
The Cure Starts Now | 501(c)(3) | Cincinnati, OH | $5,080,693 |
Cerebral Palsy Foundation (CPF) | 501(c)(3) | New York, NY | $4,021,273 |
Data update history
August 26, 2024
Posted financials
Added Form 990 for fiscal year 2023
August 26, 2024
Updated personnel
Identified 3 new personnel
Nonprofit Types
Grantmaking organizationsDisease research fundraisersDisease-focused nonprofitsCharities
Issues
HealthDiseases and disorders
Characteristics
Provides grantsConducts researchOperates internationallyNational levelEndowed supportGala fundraisersTax deductible donationsAccepts online donations
General information
- Address
- 80 Maiden LN 700
- New York, NY 10038
- Metro area
- New York-Newark-Jersey City, NY-NJ-PA
- County
- New York County, NY
- Website URL
- glaucomafoundation.org/Â
- Phone
- (212) 651-1900
- Facebook page
- The.Glaucoma.FoundationÂ
- Twitter profile
- @tgf_glaucomaÂ
IRS details
- EIN
- 13-3174839
- Fiscal year end
- December
- Taxreturn type
- Form 990
- Year formed
- 1984
- Eligible to receive tax-deductible contributions (Pub 78)
- Yes
Categorization
- NTEE code, primary
- G40: Diseases of Specific Organs
- NAICS code, primary
- 813212: Health and Disease Research Fundraising Organizations
- Parent/child status
- Independent
California AB-488 details
- AB 488 status
- May Operate or Solicit for Charitable Purposes
- Charity Registration status
- Current
- FTB status revoked
- Not revoked
- AG Registration Number
- 107968
- FTB Entity ID
- 2012578
- AB 488 data last updated ("as-of") date
- 2024-11-06
Free account sign-up
Want updates when The Glaucoma Foundation has new information, or want to find more organizations like The Glaucoma Foundation?
Create free Cause IQ account